fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ASCO 2012 Report – Trametinib delays tumour growth and extends survival in certain melanoma patients

Written by | 20 Nov 2012

by Marybeth Burke – Median progression-free survival (PFS) was significantly greater in the trametinib group, 4.8 months, vs the chemotherapy group, 1.4 months, according to a study presented

EAU 2012 Report – A study confirms the correlation between premature alopecia and prostate conditions

Written by | 6 Nov 2012

Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH),

Biologists find the cause of pain in the treatment of fair skin cancer

Written by | 28 Sep 2012

Pain caused by 2 different mechanisms Apply the ointment, light on, light off – that’s how easy it is to cure various forms of non-melanoma skin cancer. However,… read more.

New skin cancer drug cited as therapeutic breakthrough

Written by | 31 Jul 2012

by Bruce Sylvester taken from the New England Journal of Medicine (NEJM) Vismodegib (Erivedge), a new skin cancer drug for advanced basal cell carcinoma, was called “the greatest… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.